A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants

Background: The current crisis created by the coronavirus pandemic is impacting all facets of life. Coronavirus vaccines have been developed to prevent coronavirus infection and fight the pandemic. Since vaccines might be the only way to prevent and stop the spread of coronavirus. The World Health O...

Full description

Saved in:
Bibliographic Details
Published inVaccines (Basel) Vol. 9; no. 11; p. 1243
Main Authors Biswas, Md. Rafiul, Alzubaidi, Mahmood Saleh, Shah, Uzair, Abd-Alrazaq, Alaa A., Shah, Zubair
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 25.10.2021
MDPI
Subjects
Online AccessGet full text
ISSN2076-393X
2076-393X
DOI10.3390/vaccines9111243

Cover

Abstract Background: The current crisis created by the coronavirus pandemic is impacting all facets of life. Coronavirus vaccines have been developed to prevent coronavirus infection and fight the pandemic. Since vaccines might be the only way to prevent and stop the spread of coronavirus. The World Health Organization (WHO) has already approved several vaccines, and many countries have started vaccinating people. Misperceptions about vaccines persist despite the evidence of vaccine safety and efficacy. Objectives: To explore the scientific literature and find the determinants for worldwide COVID-19 vaccine hesitancy as reported in the literature. Methods: PRISMA Extension for Scoping Reviews (PRISMA-ScR) guidelines were followed to conduct a scoping review of literature on COVID-19 vaccine hesitancy and willingness to vaccinate. Several databases (e.g., MEDLINE, EMBASE, and Google Scholar) were searched to find relevant articles. Intervention- (i.e., COVID-19 vaccine) and outcome- (i.e., hesitancy) related terms were used to search in these databases. The search was conducted on 22 February 2021. Both forward and backward reference lists were checked to find further studies. Three reviewers worked independently to select articles and extract data from selected literature. Studies that used a quantitative survey to measure COVID-19 vaccine hesitancy and acceptance were included in this review. The extracted data were synthesized following the narrative approach and results were represented graphically with appropriate figures and tables. Results: 82 studies were included in this scoping review of 882 identified from our search. Sometimes, several studies had been performed in the same country, and it was observed that vaccine hesitancy was high earlier and decreased over time with the hope of vaccine efficacy. People in different countries had varying percentages of vaccine uptake (28–86.1%), vaccine hesitancy (10–57.8%), vaccine refusal (0–24%). The most common determinants affecting vaccination intention include vaccine efficacy, vaccine side effects, mistrust in healthcare, religious beliefs, and trust in information sources. Additionally, vaccination intentions are influenced by demographic factors such as age, gender, education, and region. Conclusions: The underlying factors of vaccine hesitancy are complex and context-specific, varying across time and socio-demographic variables. Vaccine hesitancy can also be influenced by other factors such as health inequalities, socioeconomic disadvantages, systemic racism, and level of exposure to misinformation online, with some factors being more dominant in certain countries than others. Therefore, strategies tailored to cultures and socio-psychological factors need to be developed to reduce vaccine hesitancy and aid informed decision-making.
AbstractList Background: The current crisis created by the coronavirus pandemic is impacting all facets of life. Coronavirus vaccines have been developed to prevent coronavirus infection and fight the pandemic. Since vaccines might be the only way to prevent and stop the spread of coronavirus. The World Health Organization (WHO) has already approved several vaccines, and many countries have started vaccinating people. Misperceptions about vaccines persist despite the evidence of vaccine safety and efficacy. Objectives: To explore the scientific literature and find the determinants for worldwide COVID-19 vaccine hesitancy as reported in the literature. Methods: PRISMA Extension for Scoping Reviews (PRISMA-ScR) guidelines were followed to conduct a scoping review of literature on COVID-19 vaccine hesitancy and willingness to vaccinate. Several databases (e.g., MEDLINE, EMBASE, and Google Scholar) were searched to find relevant articles. Intervention- (i.e., COVID-19 vaccine) and outcome- (i.e., hesitancy) related terms were used to search in these databases. The search was conducted on 22 February 2021. Both forward and backward reference lists were checked to find further studies. Three reviewers worked independently to select articles and extract data from selected literature. Studies that used a quantitative survey to measure COVID-19 vaccine hesitancy and acceptance were included in this review. The extracted data were synthesized following the narrative approach and results were represented graphically with appropriate figures and tables. Results: 82 studies were included in this scoping review of 882 identified from our search. Sometimes, several studies had been performed in the same country, and it was observed that vaccine hesitancy was high earlier and decreased over time with the hope of vaccine efficacy. People in different countries had varying percentages of vaccine uptake (28–86.1%), vaccine hesitancy (10–57.8%), vaccine refusal (0–24%). The most common determinants affecting vaccination intention include vaccine efficacy, vaccine side effects, mistrust in healthcare, religious beliefs, and trust in information sources. Additionally, vaccination intentions are influenced by demographic factors such as age, gender, education, and region. Conclusions: The underlying factors of vaccine hesitancy are complex and context-specific, varying across time and socio-demographic variables. Vaccine hesitancy can also be influenced by other factors such as health inequalities, socioeconomic disadvantages, systemic racism, and level of exposure to misinformation online, with some factors being more dominant in certain countries than others. Therefore, strategies tailored to cultures and socio-psychological factors need to be developed to reduce vaccine hesitancy and aid informed decision-making.
The current crisis created by the coronavirus pandemic is impacting all facets of life. Coronavirus vaccines have been developed to prevent coronavirus infection and fight the pandemic. Since vaccines might be the only way to prevent and stop the spread of coronavirus. The World Health Organization (WHO) has already approved several vaccines, and many countries have started vaccinating people. Misperceptions about vaccines persist despite the evidence of vaccine safety and efficacy. To explore the scientific literature and find the determinants for worldwide COVID-19 vaccine hesitancy as reported in the literature. PRISMA Extension for Scoping Reviews (PRISMA-ScR) guidelines were followed to conduct a scoping review of literature on COVID-19 vaccine hesitancy and willingness to vaccinate. Several databases (e.g., MEDLINE, EMBASE, and Google Scholar) were searched to find relevant articles. Intervention- (i.e., COVID-19 vaccine) and outcome- (i.e., hesitancy) related terms were used to search in these databases. The search was conducted on 22 February 2021. Both forward and backward reference lists were checked to find further studies. Three reviewers worked independently to select articles and extract data from selected literature. Studies that used a quantitative survey to measure COVID-19 vaccine hesitancy and acceptance were included in this review. The extracted data were synthesized following the narrative approach and results were represented graphically with appropriate figures and tables. 82 studies were included in this scoping review of 882 identified from our search. Sometimes, several studies had been performed in the same country, and it was observed that vaccine hesitancy was high earlier and decreased over time with the hope of vaccine efficacy. People in different countries had varying percentages of vaccine uptake (28-86.1%), vaccine hesitancy (10-57.8%), vaccine refusal (0-24%). The most common determinants affecting vaccination intention include vaccine efficacy, vaccine side effects, mistrust in healthcare, religious beliefs, and trust in information sources. Additionally, vaccination intentions are influenced by demographic factors such as age, gender, education, and region. The underlying factors of vaccine hesitancy are complex and context-specific, varying across time and socio-demographic variables. Vaccine hesitancy can also be influenced by other factors such as health inequalities, socioeconomic disadvantages, systemic racism, and level of exposure to misinformation online, with some factors being more dominant in certain countries than others. Therefore, strategies tailored to cultures and socio-psychological factors need to be developed to reduce vaccine hesitancy and aid informed decision-making.
The current crisis created by the coronavirus pandemic is impacting all facets of life. Coronavirus vaccines have been developed to prevent coronavirus infection and fight the pandemic. Since vaccines might be the only way to prevent and stop the spread of coronavirus. The World Health Organization (WHO) has already approved several vaccines, and many countries have started vaccinating people. Misperceptions about vaccines persist despite the evidence of vaccine safety and efficacy.BACKGROUNDThe current crisis created by the coronavirus pandemic is impacting all facets of life. Coronavirus vaccines have been developed to prevent coronavirus infection and fight the pandemic. Since vaccines might be the only way to prevent and stop the spread of coronavirus. The World Health Organization (WHO) has already approved several vaccines, and many countries have started vaccinating people. Misperceptions about vaccines persist despite the evidence of vaccine safety and efficacy.To explore the scientific literature and find the determinants for worldwide COVID-19 vaccine hesitancy as reported in the literature.OBJECTIVESTo explore the scientific literature and find the determinants for worldwide COVID-19 vaccine hesitancy as reported in the literature.PRISMA Extension for Scoping Reviews (PRISMA-ScR) guidelines were followed to conduct a scoping review of literature on COVID-19 vaccine hesitancy and willingness to vaccinate. Several databases (e.g., MEDLINE, EMBASE, and Google Scholar) were searched to find relevant articles. Intervention- (i.e., COVID-19 vaccine) and outcome- (i.e., hesitancy) related terms were used to search in these databases. The search was conducted on 22 February 2021. Both forward and backward reference lists were checked to find further studies. Three reviewers worked independently to select articles and extract data from selected literature. Studies that used a quantitative survey to measure COVID-19 vaccine hesitancy and acceptance were included in this review. The extracted data were synthesized following the narrative approach and results were represented graphically with appropriate figures and tables.METHODSPRISMA Extension for Scoping Reviews (PRISMA-ScR) guidelines were followed to conduct a scoping review of literature on COVID-19 vaccine hesitancy and willingness to vaccinate. Several databases (e.g., MEDLINE, EMBASE, and Google Scholar) were searched to find relevant articles. Intervention- (i.e., COVID-19 vaccine) and outcome- (i.e., hesitancy) related terms were used to search in these databases. The search was conducted on 22 February 2021. Both forward and backward reference lists were checked to find further studies. Three reviewers worked independently to select articles and extract data from selected literature. Studies that used a quantitative survey to measure COVID-19 vaccine hesitancy and acceptance were included in this review. The extracted data were synthesized following the narrative approach and results were represented graphically with appropriate figures and tables.82 studies were included in this scoping review of 882 identified from our search. Sometimes, several studies had been performed in the same country, and it was observed that vaccine hesitancy was high earlier and decreased over time with the hope of vaccine efficacy. People in different countries had varying percentages of vaccine uptake (28-86.1%), vaccine hesitancy (10-57.8%), vaccine refusal (0-24%). The most common determinants affecting vaccination intention include vaccine efficacy, vaccine side effects, mistrust in healthcare, religious beliefs, and trust in information sources. Additionally, vaccination intentions are influenced by demographic factors such as age, gender, education, and region.RESULTS82 studies were included in this scoping review of 882 identified from our search. Sometimes, several studies had been performed in the same country, and it was observed that vaccine hesitancy was high earlier and decreased over time with the hope of vaccine efficacy. People in different countries had varying percentages of vaccine uptake (28-86.1%), vaccine hesitancy (10-57.8%), vaccine refusal (0-24%). The most common determinants affecting vaccination intention include vaccine efficacy, vaccine side effects, mistrust in healthcare, religious beliefs, and trust in information sources. Additionally, vaccination intentions are influenced by demographic factors such as age, gender, education, and region.The underlying factors of vaccine hesitancy are complex and context-specific, varying across time and socio-demographic variables. Vaccine hesitancy can also be influenced by other factors such as health inequalities, socioeconomic disadvantages, systemic racism, and level of exposure to misinformation online, with some factors being more dominant in certain countries than others. Therefore, strategies tailored to cultures and socio-psychological factors need to be developed to reduce vaccine hesitancy and aid informed decision-making.CONCLUSIONSThe underlying factors of vaccine hesitancy are complex and context-specific, varying across time and socio-demographic variables. Vaccine hesitancy can also be influenced by other factors such as health inequalities, socioeconomic disadvantages, systemic racism, and level of exposure to misinformation online, with some factors being more dominant in certain countries than others. Therefore, strategies tailored to cultures and socio-psychological factors need to be developed to reduce vaccine hesitancy and aid informed decision-making.
Author Shah, Zubair
Abd-Alrazaq, Alaa A.
Alzubaidi, Mahmood Saleh
Shah, Uzair
Biswas, Md. Rafiul
AuthorAffiliation College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar; maal28902@hbku.edu.qa (M.S.A.); uzsh31989@hbku.edu.qa (U.S.); aabdalrazaq@hbku.edu.qa (A.A.A.-A.)
AuthorAffiliation_xml – name: College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar; maal28902@hbku.edu.qa (M.S.A.); uzsh31989@hbku.edu.qa (U.S.); aabdalrazaq@hbku.edu.qa (A.A.A.-A.)
Author_xml – sequence: 1
  givenname: Md. Rafiul
  orcidid: 0000-0002-5145-1990
  surname: Biswas
  fullname: Biswas, Md. Rafiul
– sequence: 2
  givenname: Mahmood Saleh
  surname: Alzubaidi
  fullname: Alzubaidi, Mahmood Saleh
– sequence: 3
  givenname: Uzair
  surname: Shah
  fullname: Shah, Uzair
– sequence: 4
  givenname: Alaa A.
  surname: Abd-Alrazaq
  fullname: Abd-Alrazaq, Alaa A.
– sequence: 5
  givenname: Zubair
  surname: Shah
  fullname: Shah, Zubair
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34835174$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1vEzEQQFeoiJbSMzdkiQuXUH_u2hekKqU0UqVIQAs3a9Y7Gxxt7GDvpsq_Z0NK1UbCF1v2m-cZj18XRyEGLIq3jH4UwtDzDTjnA2bDGONSvChOOK3KiTDi59GT9XFxlvOSjsMwocvqVXEspBaKVfKkgAvyzcW1DwvyFTce70kfyZUPDZkPPfkRU9fc-wbJdH43u5wwQ-72l5JrzL6H4LYERnjWZ3IbGkzddqe6xB7TygcIfX5TvGyhy3j2MJ8Wt1efv0-vJzfzL7Ppxc3EKSX6iQBZliUIzWvnsGqh1RqYUtRobmjDWxCqaliDLVeUM4dat9zwUjtpqqZGcVrM9t4mwtKuk19B2toI3v7diGlhIfXedWjBSECQjpaopDAcGiekEEqBqmsG9ej6tHeth3qFjcPQJ-ieSZ-fBP_LLuLG6pLLyvBR8OFBkOLvAXNvVz477DoIGIdseUklZVJX5Yi-P0CXcUhhfKodxTkzY-Ej9e5pRo-p_OvkCJzvAZdizgnbR4RRu_su9uC7jBHqIMKNHe193JXku__G_QHQVsVS
CitedBy_id crossref_primary_10_1080_21645515_2023_2245720
crossref_primary_10_1016_j_vaccine_2023_09_020
crossref_primary_10_3390_vaccines11061057
crossref_primary_10_1111_pops_12893
crossref_primary_10_3390_su16010436
crossref_primary_10_1016_j_heliyon_2024_e27901
crossref_primary_10_3390_vaccines10010055
crossref_primary_10_1590_0102_311xpt041423
crossref_primary_10_3390_soc14120269
crossref_primary_10_1136_bmjopen_2022_067210
crossref_primary_10_3389_fmed_2022_900026
crossref_primary_10_1007_s00296_023_05512_1
crossref_primary_10_56083_RCV4N3_084
crossref_primary_10_3390_vaccines10030467
crossref_primary_10_3389_fpubh_2022_958668
crossref_primary_10_1016_j_vaccine_2023_06_057
crossref_primary_10_1186_s13031_022_00477_7
crossref_primary_10_5798_dicletip_1411922
crossref_primary_10_3390_foods12213930
crossref_primary_10_1590_0102_311xen041423
crossref_primary_10_2147_JMDH_S341700
crossref_primary_10_29038_2306_3971_2021_02_79_86
crossref_primary_10_1136_bmjopen_2023_071566
crossref_primary_10_2478_nispa_2023_0004
crossref_primary_10_3390_bioengineering9120748
crossref_primary_10_1016_j_cger_2022_03_006
crossref_primary_10_1080_03007995_2024_2316217
crossref_primary_10_3390_ijerph20146402
crossref_primary_10_3390_vaccines11010133
crossref_primary_10_3390_vaccines11010138
crossref_primary_10_3390_vaccines10081247
crossref_primary_10_1186_s40545_022_00422_2
crossref_primary_10_1215_03616878_11513094
crossref_primary_10_1016_j_jiph_2022_06_007
crossref_primary_10_2196_64653
crossref_primary_10_1111_cbdd_14383
crossref_primary_10_1177_00469580231164229
crossref_primary_10_3390_vaccines10050760
crossref_primary_10_1186_s12889_022_14225_2
crossref_primary_10_34172_hpp_2022_51
crossref_primary_10_1080_14760584_2022_2093723
crossref_primary_10_3390_covid4040037
crossref_primary_10_54005_geneltip_1346388
crossref_primary_10_1002_iid3_950
crossref_primary_10_3390_vaccines10030365
crossref_primary_10_3389_fpubh_2022_841842
crossref_primary_10_3390_systems12050167
crossref_primary_10_1016_j_vaccine_2022_12_024
crossref_primary_10_1177_10541373231199646
crossref_primary_10_1542_peds_2022_056193
crossref_primary_10_1080_15398285_2022_2106404
crossref_primary_10_3390_vaccines10071158
crossref_primary_10_1097_MS9_0000000000000921
crossref_primary_10_26900_hsq_2113
crossref_primary_10_3390_ijerph192114550
crossref_primary_10_3390_atmos15010093
crossref_primary_10_3390_vaccines11071149
crossref_primary_10_1080_21645515_2023_2281729
crossref_primary_10_3390_vaccines10071155
crossref_primary_10_14367_kjhep_2022_39_1_1
crossref_primary_10_3390_vaccines11081339
crossref_primary_10_1007_s10389_022_01753_9
crossref_primary_10_3390_vaccines11040816
crossref_primary_10_3390_ijerph192214886
crossref_primary_10_2196_45980
crossref_primary_10_3390_agriengineering5040106
crossref_primary_10_1371_journal_pdig_0000125
crossref_primary_10_1093_heapro_daae092
crossref_primary_10_3389_fpsyg_2022_908917
crossref_primary_10_3390_vaccines11091409
crossref_primary_10_1080_14760584_2022_2105212
crossref_primary_10_1136_bmjph_2024_001240
crossref_primary_10_3390_vaccines11101516
crossref_primary_10_3390_vaccines10020214
crossref_primary_10_1007_s10900_022_01093_5
crossref_primary_10_1016_j_ijnurstu_2022_104241
crossref_primary_10_3390_vaccines10010011
crossref_primary_10_3390_w15193495
crossref_primary_10_3389_ijph_2023_1605852
crossref_primary_10_1038_s41598_022_21434_7
crossref_primary_10_3390_vaccines10081297
crossref_primary_10_1111_phn_13134
crossref_primary_10_3390_vaccines10040627
crossref_primary_10_3390_ijerph19159507
crossref_primary_10_1080_21645515_2022_2074205
crossref_primary_10_1016_S2666_7568_23_00038_7
crossref_primary_10_1093_eurpub_ckad115
crossref_primary_10_3390_vaccines11050886
crossref_primary_10_3390_vaccines10030427
crossref_primary_10_1371_journal_pone_0310884
crossref_primary_10_1016_j_puhe_2024_12_015
crossref_primary_10_3390_vaccines10030429
crossref_primary_10_3390_medicina59081403
crossref_primary_10_5114_hpr_2021_111292
crossref_primary_10_1080_00207543_2024_2329317
crossref_primary_10_1097_INF_0000000000004667
crossref_primary_10_1371_journal_pgph_0004066
crossref_primary_10_54724_lc_2023_e7
crossref_primary_10_3390_vaccines10071097
crossref_primary_10_1080_21645515_2024_2316417
crossref_primary_10_3390_atmos14121788
crossref_primary_10_1186_s12889_022_14399_9
crossref_primary_10_3389_fpubh_2024_1382849
crossref_primary_10_3390_vaccines11020403
crossref_primary_10_1093_jnci_djac204
crossref_primary_10_1136_bmjopen_2022_065453
crossref_primary_10_4103_jfmpc_jfmpc_594_24
crossref_primary_10_1080_21645515_2024_2448052
crossref_primary_10_3390_vaccines11071231
crossref_primary_10_1186_s12889_024_18674_9
crossref_primary_10_3390_vaccines10071102
crossref_primary_10_1017_S0963180125000027
crossref_primary_10_3390_antibiotics12101512
crossref_primary_10_24171_j_phrp_2024_0254
crossref_primary_10_1007_s10182_024_00520_3
crossref_primary_10_3390_vaccines12030269
crossref_primary_10_3390_su152416918
crossref_primary_10_3889_oamjms_2022_10586
crossref_primary_10_12688_f1000research_122815_1
crossref_primary_10_3390_vaccines11121822
crossref_primary_10_3390_vaccines10020230
crossref_primary_10_1016_j_jvacx_2023_100369
crossref_primary_10_1016_j_socscimed_2022_115112
crossref_primary_10_1111_dpr_12645
crossref_primary_10_3389_fpubh_2023_1162861
crossref_primary_10_1002_hsr2_1203
crossref_primary_10_1186_s42506_023_00142_8
crossref_primary_10_1007_s41651_023_00154_0
crossref_primary_10_20473_jfk_v10i2_46888
crossref_primary_10_1080_21645515_2023_2269777
crossref_primary_10_3390_ijerph19074205
crossref_primary_10_1080_10810730_2022_2148021
crossref_primary_10_2196_56390
Cites_doi 10.1093/her/cyaa043
10.3390/vaccines8040576
10.1371/journal.pone.0250555
10.3389/fpubh.2021.698111
10.3389/fpubh.2020.00381
10.1017/S003329172100101X
10.1016/j.vaccine.2020.08.043
10.1371/journal.pntd.0008961
10.2139/ssrn.3593098
10.1016/j.vaccine.2020.09.084
10.1007/s10198-020-01208-6
10.1017/S0033291720005188
10.2196/17828
10.1101/2020.11.18.20234468
10.1017/S0033291720004067
10.1080/21645515.2020.1819741
10.1101/2021.01.03.21249184
10.1097/QAI.0000000000002570
10.1016/j.eclinm.2021.100863
10.3389/fpsyg.2020.565128
10.1016/j.amepre.2018.04.010
10.1371/journal.pone.0245907
10.1101/2020.12.28.20248950
10.1016/j.jhin.2020.11.020
10.1080/21645515.2020.1853449
10.3390/vaccines9010017
10.1101/2020.11.26.20239483
10.1007/s10900-020-00958-x
10.3390/vaccines9010042
10.1111/hex.13140
10.1007/s10654-020-00675-8
10.1111/irv.12847
10.1038/s41591-020-01226-0
10.3390/ijerph18020797
10.1371/journal.pone.0246970
10.2196/24827
10.3390/vaccines9010044
10.1016/j.msard.2021.102788
10.1111/jgs.17022
10.1186/s12879-021-05833-1
10.2147/JMDH.S276771
10.1016/j.annonc.2021.01.066
10.1101/2021.03.16.21253767
10.1007/s10198-008-0124-3
10.3390/vaccines9080900
10.1016/j.immuni.2020.04.012
10.1007/s10900-021-00993-2
10.3389/fpsyg.2020.575950
10.3390/jcm10071428
10.1016/S2468-2667(21)00012-8
10.1016/j.vaccine.2020.12.032
10.1016/j.vaccine.2020.07.013
10.1016/j.vaccine.2020.09.021
10.2147/POR.S271096
10.1016/j.ijnurstu.2020.103854
10.1007/s10943-020-01090-9
10.12788/jhm.3248
10.1080/21645515.2020.1817712
10.1111/bjhp.12468
10.1016/j.vaccine.2020.10.027
10.1016/j.ijmedinf.2019.103978
10.1016/S1473-3099(20)30426-6
10.1001/jamanetworkopen.2020.25594
10.1080/21645515.2020.1847585
10.2807/1560-7917.ES.2021.26.3.2002047
10.1186/s13643-016-0384-4
10.7326/M18-0850
10.1080/21645515.2020.1846397
10.1186/s41256-021-00188-1
10.1136/bmj.n513
10.1097/JOM.0000000000002152
10.1016/j.jceh.2020.06.003
10.1186/s13584-016-0062-y
10.31234/osf.io/r8h6z
10.1108/01409170410784185
10.1001/jama.2020.26419
10.1016/j.micinf.2020.09.005
10.1016/j.vaccine.2021.01.010
10.3390/vaccines8030482
10.1016/S0264-410X(98)00302-8
10.1007/s10654-020-00670-z
10.1016/j.vaccine.2020.09.041
10.20944/preprints202009.0338.v1
10.1016/j.eclinm.2020.100495
10.1016/j.vaccine.2020.12.083
10.1136/postgradmedj-2020-138903
10.1016/j.paid.2020.110590
10.1016/j.ajic.2020.11.018
10.1080/21645515.2020.1829315
10.1016/j.tics.2021.02.002
10.1038/s41591-021-01454-y
10.31234/osf.io/pev2b
10.1586/14760584.2015.964212
10.1001/jamanetworkopen.2020.33324
10.1016/j.socscimed.2020.113638
10.1016/j.socscimed.2021.113688
10.7326/M20-3569
ContentType Journal Article
Copyright 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
NPM
3V.
7T7
7XB
8FD
8FE
8FH
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
COVID
DWQXO
FR3
GNUQQ
GUQSH
HCIFZ
LK8
M2O
M7P
MBDVC
P64
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/vaccines9111243
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (purchase pre-March 2016)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
Coronavirus Research Database
ProQuest Central
Engineering Research Database
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
Biological Sciences
ProQuest research library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Coronavirus Research Database
Biological Science Database
ProQuest SciTech Collection
Biotechnology and BioEngineering Abstracts
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
Publicly Available Content Database
PubMed
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2076-393X
ExternalDocumentID oai_doaj_org_article_a94aea4c06e54392adc343355a5bb1ab
PMC8624792
34835174
10_3390_vaccines9111243
Genre Journal Article
Scoping Review
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GroupedDBID 53G
5VS
8FE
8FH
8G5
AADQD
AAHBH
AAYXX
ABUWG
ADBBV
AEUYN
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
CCPQU
CITATION
DIK
DWQXO
GNUQQ
GROUPED_DOAJ
GUQSH
HCIFZ
HYE
IAO
IHR
ITC
KQ8
LK8
M2O
M48
M7P
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RNS
RPM
NPM
PQGLB
3V.
7T7
7XB
8FD
8FK
C1K
COVID
FR3
MBDVC
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c553t-3a4666a382bcce7faf88a155098290d2fa357d1def25021ce88f29268c497dbe3
IEDL.DBID BENPR
ISSN 2076-393X
IngestDate Wed Aug 27 01:31:52 EDT 2025
Thu Aug 21 14:07:17 EDT 2025
Fri Sep 05 13:01:03 EDT 2025
Fri Jul 25 09:30:53 EDT 2025
Mon Jul 21 06:05:06 EDT 2025
Thu Apr 24 23:11:16 EDT 2025
Tue Jul 01 02:25:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords COVID-19
coverage
vaccine safety
SARS-COV2
determinants
acceptance
PRISMA
hesitancy
vaccine efficacy
scoping review
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c553t-3a4666a382bcce7faf88a155098290d2fa357d1def25021ce88f29268c497dbe3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-5145-1990
OpenAccessLink https://www.proquest.com/docview/2602219357?pq-origsite=%requestingapplication%&accountid=15518
PMID 34835174
PQID 2602219357
PQPubID 2032320
ParticipantIDs doaj_primary_oai_doaj_org_article_a94aea4c06e54392adc343355a5bb1ab
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8624792
proquest_miscellaneous_2604014876
proquest_journals_2602219357
pubmed_primary_34835174
crossref_primary_10_3390_vaccines9111243
crossref_citationtrail_10_3390_vaccines9111243
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20211025
PublicationDateYYYYMMDD 2021-10-25
PublicationDate_xml – month: 10
  year: 2021
  text: 20211025
  day: 25
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Vaccines (Basel)
PublicationTitleAlternate Vaccines (Basel)
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References ref_93
Khuroo (ref_103) 2020; 10
Zhang (ref_51) 2020; 3
Ruiz (ref_27) 2021; 39
Randolph (ref_2) 2020; 52
ref_98
ref_95
Barello (ref_21) 2020; 35
Chen (ref_53) 2021; 17
Haghpanah (ref_104) 2021; 35
Caserotti (ref_46) 2021; 272
Fu (ref_50) 2020; 2962
Alajlani (ref_17) 2021; 23
Goldman (ref_91) 2020; 38
Prati (ref_49) 2020; 35
ref_22
ref_20
Daley (ref_8) 2018; 55
Detoc (ref_58) 2020; 38
Seror (ref_89) 2020; 20
Karlsson (ref_43) 2021; 172
ref_26
Detoc (ref_59) 2021; 108
Razai (ref_94) 2021; 372
Williams (ref_64) 2020; 25
Zhang (ref_52) 2021; 17
ref_72
Unroe (ref_11) 2021; 69
Sucharew (ref_13) 2019; 14
Mercadante (ref_38) 2020; 14
ref_78
Rowley (ref_14) 2004; 27
ref_77
Harapan (ref_80) 2020; 16
Bertin (ref_56) 2020; 11
Olagoke (ref_92) 2021; 60
Ouzzani (ref_18) 2016; 5
Guidry (ref_40) 2021; 49
Negri (ref_48) 2020; 111
Chevallier (ref_7) 2021; 25
Hotez (ref_96) 2020; 22
Kumar (ref_74) 2016; 5
Taylor (ref_73) 2020; 11
Sherman (ref_97) 2021; 17
ref_87
Biasio (ref_3) 2021; 17
ref_86
ref_85
Shahrabani (ref_19) 2009; 10
Kwok (ref_71) 2021; 114
Alabdulla (ref_82) 2021; 15
Cassidy (ref_101) 2021; 9
Bell (ref_65) 2020; 38
Kose (ref_75) 2021; 75
Padhi (ref_83) 2020; 13
Callaghan (ref_5) 2021; 272
Malik (ref_24) 2020; 26
Kane (ref_88) 1998; 16
Gal (ref_23) 2021; 32
ref_61
Borriello (ref_67) 2021; 39
Harapan (ref_79) 2020; 8
Palamenghi (ref_47) 2020; 35
ref_69
ref_68
ref_66
Ehde (ref_34) 2021; 49
ref_62
Bogart (ref_33) 2021; 86
Silvera (ref_29) 2021; 63
Seale (ref_70) 2021; 21
Vivion (ref_9) 2015; 14
Fisher (ref_32) 2020; 173
Schwarzinger (ref_57) 2021; 6
Wang (ref_55) 2020; 38
Tricco (ref_15) 2018; 169
ref_36
ref_35
Alqudeimat (ref_84) 2021; 10
ref_31
ref_30
Kourlaba (ref_81) 2021; 6
Reiter (ref_39) 2020; 38
Yang (ref_54) 2021; 17
Largent (ref_42) 2020; 3
Verger (ref_60) 2021; 26
Arce (ref_99) 2021; 27
Kreps (ref_28) 2020; 3
ref_105
Webster (ref_12) 2002; 26
ref_45
ref_100
Wong (ref_25) 2021; 39
ref_41
ref_102
Dong (ref_6) 2020; 23
ref_1
Varghese (ref_76) 2020; 21
Alajlani (ref_16) 2019; 132
Khubchandani (ref_37) 2021; 46
Kochhar (ref_90) 2020; 38
Marcec (ref_63) 2020; 97
ref_4
Lungoyo (ref_10) 2020; 11
Szilagyi (ref_44) 2021; 325
References_xml – volume: 35
  start-page: 505
  year: 2020
  ident: ref_49
  article-title: Intention to receive a vaccine against SARS-CoV-2 in Italy and its association with trust, worry and beliefs about the origin of the virus
  publication-title: Health Educ. Res.
  doi: 10.1093/her/cyaa043
– ident: ref_45
  doi: 10.3390/vaccines8040576
– ident: ref_86
  doi: 10.1371/journal.pone.0250555
– ident: ref_98
  doi: 10.3389/fpubh.2021.698111
– volume: 8
  start-page: 381
  year: 2020
  ident: ref_79
  article-title: Acceptance of a COVID-19 Vaccine in Southeast Asia: A cross-sectional study in Indonesia
  publication-title: Front. Public Health
  doi: 10.3389/fpubh.2020.00381
– ident: ref_1
– ident: ref_20
  doi: 10.1017/S003329172100101X
– volume: 38
  start-page: 6500
  year: 2020
  ident: ref_39
  article-title: Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2020.08.043
– ident: ref_22
  doi: 10.1371/journal.pntd.0008961
– ident: ref_36
  doi: 10.2139/ssrn.3593098
– volume: 38
  start-page: 7668
  year: 2020
  ident: ref_91
  article-title: Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2020.09.084
– volume: 21
  start-page: 977
  year: 2020
  ident: ref_76
  article-title: Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19
  publication-title: Eur. J. Health Econ.
  doi: 10.1007/s10198-020-01208-6
– ident: ref_66
  doi: 10.1017/S0033291720005188
– volume: 23
  start-page: e17828
  year: 2021
  ident: ref_17
  article-title: Perceptions and opinions of patients about mental health chatbots: Scoping review
  publication-title: J. Med. Internet Res.
  doi: 10.2196/17828
– ident: ref_35
  doi: 10.1101/2020.11.18.20234468
– ident: ref_62
  doi: 10.1017/S0033291720004067
– volume: 16
  start-page: 3074
  year: 2020
  ident: ref_80
  article-title: Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia
  publication-title: Hum. Vaccines Immunother.
  doi: 10.1080/21645515.2020.1819741
– ident: ref_30
  doi: 10.1101/2021.01.03.21249184
– volume: 86
  start-page: 200
  year: 2021
  ident: ref_33
  article-title: COVID-19 related medical mistrust, health impacts, and potential vaccine hesitancy among black americans living with HIV
  publication-title: JAIDS J. Acquir. Immune Defic. Syndr.
  doi: 10.1097/QAI.0000000000002570
– volume: 10
  start-page: 2052
  year: 2021
  ident: ref_84
  article-title: Acceptance of a COVID-19 Vaccine and its related determinants among the general adult population in Kuwait
  publication-title: Med. Princ. Pr.
– volume: 35
  start-page: 100863
  year: 2021
  ident: ref_104
  article-title: Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality
  publication-title: EClinicalMedicine
  doi: 10.1016/j.eclinm.2021.100863
– volume: 11
  start-page: 1
  year: 2020
  ident: ref_56
  article-title: Conspiracy beliefs, rejection of vaccination, and support for hydroxychloroquine: A conceptual replication-extension in the COVID-19 pandemic context
  publication-title: Front. Psychol.
  doi: 10.3389/fpsyg.2020.565128
– volume: 55
  start-page: 44
  year: 2018
  ident: ref_8
  article-title: Addressing parents’ vaccine concerns: A randomized trial of a social media intervention
  publication-title: Am. J. Prev. Med.
  doi: 10.1016/j.amepre.2018.04.010
– ident: ref_68
  doi: 10.1371/journal.pone.0245907
– ident: ref_93
  doi: 10.1101/2020.12.28.20248950
– volume: 9
  start-page: 1385
  year: 2021
  ident: ref_101
  article-title: A Behavioral analysis of nurses’ and pharmacists’ role in addressing vaccine hesitancy: Scoping review
  publication-title: Nat. Med.
– volume: 108
  start-page: 168
  year: 2021
  ident: ref_59
  article-title: Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: A cross-sectional survey
  publication-title: J. Hosp. Infect.
  doi: 10.1016/j.jhin.2020.11.020
– volume: 17
  start-page: 2279
  year: 2021
  ident: ref_53
  article-title: An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination
  publication-title: Hum. Vaccines Immunother.
  doi: 10.1080/21645515.2020.1853449
– ident: ref_77
  doi: 10.3390/vaccines9010017
– ident: ref_26
  doi: 10.1101/2020.11.26.20239483
– volume: 26
  start-page: xiii
  year: 2002
  ident: ref_12
  article-title: Analyzing the Past to Prepare for the Future: Writing a Literature Review
  publication-title: MIS Q.
– volume: 46
  start-page: 270
  year: 2021
  ident: ref_37
  article-title: COVID-19 Vaccination hesitancy in the United States: A rapid national assessment
  publication-title: J. Community Health
  doi: 10.1007/s10900-020-00958-x
– ident: ref_85
  doi: 10.3390/vaccines9010042
– volume: 23
  start-page: 1543
  year: 2020
  ident: ref_6
  article-title: Public preference for COVID-19 vaccines in China: A discrete choice experiment
  publication-title: Health Expect
  doi: 10.1111/hex.13140
– volume: 35
  start-page: 785
  year: 2020
  ident: ref_47
  article-title: Mistrust in biomedical research and vaccine hesitancy: The forefront challenge in the battle against COVID-19 in Italy
  publication-title: Eur. J. Epidemiol.
  doi: 10.1007/s10654-020-00675-8
– volume: 15
  start-page: 361
  year: 2021
  ident: ref_82
  article-title: COVID-19 vaccine hesitancy and attitudes in Qatar: A national cross-sectional survey of a migrant-majority population
  publication-title: Influenza Other Respir. Viruses
  doi: 10.1111/irv.12847
– ident: ref_87
  doi: 10.1038/s41591-020-01226-0
– ident: ref_69
  doi: 10.3390/ijerph18020797
– ident: ref_31
  doi: 10.1371/journal.pone.0246970
– volume: 3
  start-page: e24827
  year: 2020
  ident: ref_51
  article-title: Parental acceptability of COVID-19 vaccination for children under the age of 18 years: Cross-sectional online survey
  publication-title: JMIR Pediatr. Parent.
  doi: 10.2196/24827
– ident: ref_78
  doi: 10.3390/vaccines9010044
– volume: 49
  start-page: 102788
  year: 2021
  ident: ref_34
  article-title: Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States
  publication-title: Mult. Scler. Relat. Disord.
  doi: 10.1016/j.msard.2021.102788
– volume: 111
  start-page: 445
  year: 2020
  ident: ref_48
  article-title: Attitudes towards influenza vaccine and a potential COVID-19 vaccine in Italy and differences across occupational groups, September 2020
  publication-title: Med. Lav
– volume: 69
  start-page: 593
  year: 2021
  ident: ref_11
  article-title: Willingness of long-term care staff to receive a COVID-19 vaccine: A single state survey
  publication-title: J. Am. Geriatr. Soc.
  doi: 10.1111/jgs.17022
– volume: 21
  start-page: 1
  year: 2021
  ident: ref_70
  article-title: Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine
  publication-title: BMC Infect. Dis.
  doi: 10.1186/s12879-021-05833-1
– volume: 13
  start-page: 1657
  year: 2020
  ident: ref_83
  article-title: Determinants of COVID-19 vaccine acceptance in Saudi Arabia: A web-based national survey
  publication-title: J. Multidiscotlandip. Health
  doi: 10.2147/JMDH.S276771
– volume: 32
  start-page: 673
  year: 2021
  ident: ref_23
  article-title: Acceptance of SARS-CoV-2 vaccination among French patients with cancer: A cross-sectional survey
  publication-title: Ann. Oncol.
  doi: 10.1016/j.annonc.2021.01.066
– ident: ref_102
  doi: 10.1101/2021.03.16.21253767
– volume: 10
  start-page: 227
  year: 2009
  ident: ref_19
  article-title: Factors affecting nurses’ decision to get the flu vaccine
  publication-title: Eur. J. Health Econ.
  doi: 10.1007/s10198-008-0124-3
– ident: ref_100
  doi: 10.3390/vaccines9080900
– volume: 52
  start-page: 737
  year: 2020
  ident: ref_2
  article-title: Herd immunity: Understanding COVID-19
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.04.012
– ident: ref_95
  doi: 10.1007/s10900-021-00993-2
– volume: 11
  start-page: 575950
  year: 2020
  ident: ref_73
  article-title: A proactive approach for managing COVID-19: The importance of understanding the motivational roots of vaccination hesitancy for SARS-CoV2
  publication-title: Front. Psychol.
  doi: 10.3389/fpsyg.2020.575950
– ident: ref_105
  doi: 10.3390/jcm10071428
– volume: 6
  start-page: e210
  year: 2021
  ident: ref_57
  article-title: COVID-19 vaccine hesitancy in a representative working-age population in France: A survey experiment based on vaccine characteristics
  publication-title: Lancet Public Health
  doi: 10.1016/S2468-2667(21)00012-8
– volume: 39
  start-page: 473
  year: 2021
  ident: ref_67
  article-title: Preferences for a COVID-19 vaccine in Australia
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2020.12.032
– volume: 38
  start-page: 6194
  year: 2020
  ident: ref_90
  article-title: Planning for COVID-19 vaccines safety surveillance
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2020.07.013
– volume: 38
  start-page: 7049
  year: 2020
  ident: ref_55
  article-title: Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2020.09.021
– volume: 11
  start-page: 103
  year: 2020
  ident: ref_10
  article-title: Acceptability of vaccination against COVID-19 among healthcare workers in the democratic republic of the Congo
  publication-title: Pragmatic Obs. Res.
  doi: 10.2147/POR.S271096
– volume: 114
  start-page: 103854
  year: 2021
  ident: ref_71
  article-title: Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey
  publication-title: Int. J. Nurs. Stud.
  doi: 10.1016/j.ijnurstu.2020.103854
– volume: 60
  start-page: 65
  year: 2021
  ident: ref_92
  article-title: Intention to vaccinate against the novel 2019 Coronavirus disease: The role of health locus of control and religiosity
  publication-title: J. Relig. Health
  doi: 10.1007/s10943-020-01090-9
– volume: 14
  start-page: 416
  year: 2019
  ident: ref_13
  article-title: Methods for research evidence synthesis: The scoping review approach
  publication-title: J. Hosp. Med.
  doi: 10.12788/jhm.3248
– volume: 17
  start-page: 408
  year: 2021
  ident: ref_54
  article-title: A study on willingness and influencing factors to receive COVID-19 vaccination among Qingdao residents
  publication-title: Hum. Vaccines Immunother.
  doi: 10.1080/21645515.2020.1817712
– volume: 25
  start-page: 1039
  year: 2020
  ident: ref_64
  article-title: Towards intervention development to increase the uptake of COVID-19 vaccination among those at high risk: Outlining evidence-based and theoretically informed future intervention content
  publication-title: Br. J. Health Psychol.
  doi: 10.1111/bjhp.12468
– volume: 2962
  start-page: 548
  year: 2020
  ident: ref_50
  article-title: Acceptance and preference for COVID-19 vaccination in healthcare workers (HCWs)
  publication-title: Medrxiv
– volume: 38
  start-page: 7789
  year: 2020
  ident: ref_65
  article-title: Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2020.10.027
– volume: 132
  start-page: 103978
  year: 2019
  ident: ref_16
  article-title: An overview of the features of chatbots in mental health: A scoping review
  publication-title: Int. J. Med. Inform.
  doi: 10.1016/j.ijmedinf.2019.103978
– volume: 20
  start-page: 769
  year: 2020
  ident: ref_89
  article-title: A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(20)30426-6
– volume: 3
  start-page: e2025594
  year: 2020
  ident: ref_28
  article-title: Factors associated with US adults’ likelihood of accepting COVID-19 vaccination
  publication-title: JAMA Netw. Open
  doi: 10.1001/jamanetworkopen.2020.25594
– volume: 17
  start-page: 1622
  year: 2021
  ident: ref_52
  article-title: Willingness of the general population to accept and pay for COVID-19 vaccination during the early stages of COVID-19 pandemic: A nationally representative survey in mainland China
  publication-title: Hum. Vaccines Immunother.
  doi: 10.1080/21645515.2020.1847585
– volume: 26
  start-page: 2002047
  year: 2021
  ident: ref_60
  article-title: Attitudes of healthcare workers towards COVID-19 vaccination: A survey in France and French-speaking parts of Belgium and Canada, 2020
  publication-title: Eurosurveillance
  doi: 10.2807/1560-7917.ES.2021.26.3.2002047
– volume: 5
  start-page: 210
  year: 2016
  ident: ref_18
  article-title: Rayyan—A web and mobile app for systematic reviews
  publication-title: Syst. Rev.
  doi: 10.1186/s13643-016-0384-4
– volume: 169
  start-page: 467
  year: 2018
  ident: ref_15
  article-title: PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation
  publication-title: Ann. Intern. Med.
  doi: 10.7326/M18-0850
– volume: 17
  start-page: 1612
  year: 2021
  ident: ref_97
  article-title: COVID-19 vaccination intention in the UK: Results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey
  publication-title: Hum. Vaccines Immunother.
  doi: 10.1080/21645515.2020.1846397
– volume: 6
  start-page: 1
  year: 2021
  ident: ref_81
  article-title: Willingness of Greek general population to get a COVID-19 vaccine
  publication-title: Glob. Health Res. Policy
  doi: 10.1186/s41256-021-00188-1
– volume: 372
  start-page: n513
  year: 2021
  ident: ref_94
  article-title: Covid-19 vaccine hesitancy among ethnic minority groups
  publication-title: BMJ
  doi: 10.1136/bmj.n513
– volume: 63
  start-page: 369
  year: 2021
  ident: ref_29
  article-title: COVID-19 vaccine acceptability among us firefighters and emergency medical services workers
  publication-title: J. Occup. Environ. Med.
  doi: 10.1097/JOM.0000000000002152
– volume: 10
  start-page: 610
  year: 2020
  ident: ref_103
  article-title: COVID-19 vaccines: A race against time in the middle of death and devastation!
  publication-title: J. Clin. Exp. Hepatol.
  doi: 10.1016/j.jceh.2020.06.003
– volume: 5
  start-page: 1
  year: 2016
  ident: ref_74
  article-title: Vaccine hesitancy: Understanding better to address better
  publication-title: Isr. J. Health Policy Res.
  doi: 10.1186/s13584-016-0062-y
– ident: ref_4
  doi: 10.31234/osf.io/r8h6z
– volume: 14
  start-page: 337
  year: 2020
  ident: ref_38
  article-title: Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 The COVID-19 resource centre is hosted on Elsevier Connect the company’s public news and information
  publication-title: Diabetes Metab. Syndr.
– volume: 27
  start-page: 31
  year: 2004
  ident: ref_14
  article-title: Conducting a literature review
  publication-title: Manag. Res. News
  doi: 10.1108/01409170410784185
– volume: 325
  start-page: 396
  year: 2021
  ident: ref_44
  article-title: National trends in the US public’s likelihood of getting a COVID-19 vaccine—April 1 to December 8, 2020
  publication-title: JAMA
  doi: 10.1001/jama.2020.26419
– volume: 22
  start-page: 505
  year: 2020
  ident: ref_96
  article-title: Anti-science extremism in America: Escalating and globalizing
  publication-title: Microbes Infect.
  doi: 10.1016/j.micinf.2020.09.005
– volume: 39
  start-page: 1080
  year: 2021
  ident: ref_27
  article-title: Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2021.01.010
– ident: ref_72
  doi: 10.3390/vaccines8030482
– volume: 16
  start-page: S73
  year: 1998
  ident: ref_88
  article-title: Discotlandussion
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(98)00302-8
– volume: 35
  start-page: 781
  year: 2020
  ident: ref_21
  article-title: ‘Vaccine hesitancy’ among university students in Italy during the COVID-19 pandemic
  publication-title: Eur. J. Epidemiol.
  doi: 10.1007/s10654-020-00670-z
– volume: 38
  start-page: 7002
  year: 2020
  ident: ref_58
  article-title: Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2020.09.041
– ident: ref_41
  doi: 10.20944/preprints202009.0338.v1
– volume: 26
  start-page: 100495
  year: 2020
  ident: ref_24
  article-title: Determinants of COVID-19 vaccine acceptance in the US
  publication-title: EClinicalMedicine
  doi: 10.1016/j.eclinm.2020.100495
– volume: 39
  start-page: 1148
  year: 2021
  ident: ref_25
  article-title: Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2020.12.083
– volume: 97
  start-page: 143
  year: 2020
  ident: ref_63
  article-title: Will vaccination refusal prolong the war on SARS-CoV-2?
  publication-title: Postgrad. Med. J.
  doi: 10.1136/postgradmedj-2020-138903
– volume: 172
  start-page: 110590
  year: 2021
  ident: ref_43
  article-title: Fearing the disease or the vaccine: The case of COVID-19
  publication-title: Personal. Individ. Differ.
  doi: 10.1016/j.paid.2020.110590
– volume: 49
  start-page: 137
  year: 2021
  ident: ref_40
  article-title: Willingness to get the COVID-19 vaccine with and without emergency use authorization
  publication-title: Am. J. Infect. Control.
  doi: 10.1016/j.ajic.2020.11.018
– volume: 17
  start-page: 1304
  year: 2021
  ident: ref_3
  article-title: Assessing COVID-19 vaccine literacy: A preliminary online survey
  publication-title: Hum. Vaccines Immunother.
  doi: 10.1080/21645515.2020.1829315
– volume: 25
  start-page: 331
  year: 2021
  ident: ref_7
  article-title: COVID-19 vaccine hesitancy: Shortening the last mile
  publication-title: Trends Cogn. Sci.
  doi: 10.1016/j.tics.2021.02.002
– volume: 27
  start-page: 1385
  year: 2021
  ident: ref_99
  article-title: COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01454-y
– ident: ref_61
  doi: 10.31234/osf.io/pev2b
– volume: 14
  start-page: 99
  year: 2015
  ident: ref_9
  article-title: Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: Influence, impact and implications
  publication-title: Expert Rev. Vaccines
  doi: 10.1586/14760584.2015.964212
– volume: 3
  start-page: e2033324
  year: 2020
  ident: ref_42
  article-title: US public attitudes toward COVID-19 vaccine mandates
  publication-title: JAMA Netw. Open
  doi: 10.1001/jamanetworkopen.2020.33324
– volume: 272
  start-page: 113638
  year: 2021
  ident: ref_5
  article-title: Correlates and disparities of intention to vaccinate against COVID-19
  publication-title: Soc. Sci. Med.
  doi: 10.1016/j.socscimed.2020.113638
– volume: 272
  start-page: 113688
  year: 2021
  ident: ref_46
  article-title: Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents
  publication-title: Soc. Sci. Med.
  doi: 10.1016/j.socscimed.2021.113688
– volume: 75
  start-page: 17
  year: 2021
  ident: ref_75
  article-title: Vaccine hesitancy of the COVID-19 by health care personnel
  publication-title: Int. J. Clin. Pr.
– volume: 173
  start-page: 964
  year: 2020
  ident: ref_32
  article-title: Attitudes toward a potential SARS-CoV-2 vaccine: A survey of US adults
  publication-title: Ann. Intern. Med.
  doi: 10.7326/M20-3569
SSID ssj0000913867
Score 2.5557535
SecondaryResourceType review_article
Snippet Background: The current crisis created by the coronavirus pandemic is impacting all facets of life. Coronavirus vaccines have been developed to prevent...
The current crisis created by the coronavirus pandemic is impacting all facets of life. Coronavirus vaccines have been developed to prevent coronavirus...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1243
SubjectTerms acceptance
Coronaviruses
COVID-19
COVID-19 vaccines
Data collection
Decision making
Demographic variables
Demographics
determinants
False information
Gender
Graphical representations
Health care
Herd immunity
hesitancy
Information sources
Literature reviews
Pandemics
PRISMA
Psychological factors
Racism
scoping review
Search engines
Severe acute respiratory syndrome coronavirus 2
Side effects
Social networks
Software
Systematic Review
Vaccine efficacy
Vaccines
Viral diseases
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqTr1ULX2lQOVKFeqBQOJX4iOFrpZKLUgFxC2aOI5AQlnEZkH8e2bssOyiol56jSeRH_OMZ75h7KtTtXaF8ymKjkiV0joF02QpOK1MpsikUYHzr99mfKJ-numzhVZflBMW4YHjxu2AVeBBucx4jcZTQOOkkmglQdd1DjVp38xmC8FU0ME2l6UpIpaPxLh-5wYc3VRPSbiFkktmKKD1_83FfJopuWB6Rq_Zq8Fn5Ltxrm_YC9-tss2jCDp9t8WPH2uoplt8kx89wlHfvWWwy_-4UBbF40UA7yd8hKE4P5z1PCTT3F40nu8dnh7sp7nlp3ENfEwtA0j5ckDig37KQ5OkSyqM4vsLaTTv2Mnox_HeOB0aK6ROa9mnEhRGLSBLUTvnixbasgSKVSxdqzaiBamLJm98iw6SyJ0vy1ZYYUqnbNHUXr5nK92k8x8ZF9K4Ns8seCOVbYw1PlOQ1cZDbvHbCdt-2OfKDajj1PzissLogw6menIwCfs2f-EqAm48T_qdDm5ORkjZ4QHyTzXwT_Uv_knY-sOxV4P4TisM8gSqctyFhH2ZD6Pg0W0KdH4yCzSKfscWJmEfIpfMZyIVOrYY6yWsWOKfpakuj3QX5wHcmwp2Cis-_Y-1rbGXglJw0NQKvc5W-uuZ30Afqq8_B3G5BzGiHQg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgvPCCNj6zjclIaOJhGYm_Ej-gaWxUHdLYJNZpb9HFcWBSlUKbAv3vuUvSdp0Kr7EdOb473_1yX4y9dSrXLnE-RNERoVJah2CKKASnlYkUqTRKcD7_YvoD9flG3yzbAXUHOFkL7aif1GA8PPzzc3aEAv-BECdC9ve_wJETekJyK5R8yB6hWhLE4uedrd9cyzaWqUna8j7r1q1opqaA_zqr837w5B1t1NtkTzozkh-3dN9iD3z1lO1ftnWoZwf8aplWNTng-_xyWaF69ozBMf_qmkwp3voGeD3iPUTn_GJa8ya-5vdt4fnJxfXZaRhbft1-A-9TFwG6jzng5LN6wpu-SUPKleKndyJrnrNB79PVST_sei2ETmtZhxIUAhmQqcid80kJZZoCwRdLntZClCB1UsSFL9FmErHzaVoKK0zqlE2K3MsXbKMaVf4V40IaV8aRBW-ksoWxxkcKotx4iC2-O2CH83POXFeInPphDDMEJESY7B5hAvZuseBHW4Pj31M_EuEW06h4dvNgNP6WdbKYgVXgQbnIeI32mIDCSSXR8AKd5zHkAdudkz2bM2SGuE_g7Y6nELA3i2GURXKwQOVH02aOoj-0iQnYy5ZLFjuRCm1dhH8BS1b4Z2WrqyPV7fem3jfl8CRWbP9_WzvssaB4G9SrQu-yjXo89a_RYKrzvUYQ_gLEwxft
  priority: 102
  providerName: Scholars Portal
Title A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants
URI https://www.ncbi.nlm.nih.gov/pubmed/34835174
https://www.proquest.com/docview/2602219357
https://www.proquest.com/docview/2604014876
https://pubmed.ncbi.nlm.nih.gov/PMC8624792
https://doaj.org/article/a94aea4c06e54392adc343355a5bb1ab
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB6V7YUL4k2gVEZCFYeGJn4lOSDU12qL1O0K2qq3yLEdqFQlpZsF9d_jcR7brYBLDrEdOR6P5-GZbwDea14InWgbOtahIedChEqaKFRacBlxFGmY4Hw8lZMz_uVCXKzBtM-FwbDK_kz0B7WpNfrId5zeTR13MZF8vv4ZYtUovF3tS2iorrSC-eQhxh7AOsWqyiNY3zuczr4OXhdEwUxl0mL8MGfv7_xyQzHAHJmecrYinjyK_99Uz_sRlHdE0vgxPOp0SbLbEv8JrNnqKWzNWjDq221yusytmm-TLTJbwlTfPgO1S75pny5F2gsC0tRk7Ex0crJoiA-y-X1pLNk_OT86COOMnLf_QCZYSgAPZaJc56NmTnzxpCtMmCIHd8JrnsPZ-PB0fxJ2BRdCLQRrQqa4s2YUS2mhtU1KVaapQhsmw-tWQ0vllt_ExpZOcaKxtmla0ozKVPMsMYVlL2BU1ZV9BYQyqcs4ypSVjGdGZtJGXEWFtCrO3LcD-Nivc647NHIsinGVO6sECZPfI0wAH4YB1y0Qx7-77iHhhm6IoO1f1Dff844hc5VxZRXXkbTCKWVUGc04c9qXEkURqyKAjZ7secfW83y5CQN4NzQ7hsRbFlXZeuH7cHTTJjKAl-0uGWbCuFN4nQ0YQLKyf1amutpSXf7woN-YyJNk9PX_p_UGHlIMunHClYoNGDU3C_vWaU1Nsdmxwqb3OrjnMU__ADNdHDg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwELbG9gAviN8EBhgJJh4WltiOEz9MaFtXtWzrKuimvQXHdqDSlI41Zeo_x9_GXZK26wS87TV2Eifnu_ts331HyDsjssjExvmgOswXIop8LW3gaxMJGQh0aZjgfNSTnRPx-Sw6WyG_Z7kwGFY5s4mVobYjg3vkW4C7GWgXj-JPFz99rBqFp6uzEhq6Ka1gtyuKsSax48BNr2AJN97utkDe7xlr7w_2On5TZcA3UcRLn2sBEF7zhGXGuDjXeZJoBO4KzxgtyzW804bW5YAWWGhckuRMMZkYoWKbOQ7PvUPWAHZw0Kq13f1e_8t8lwdZNxMZ15xCnKtg6xcMFQPa0cgwwZfcYVU14G9Q92bE5jUX2H5A7jfYle7Uk-0hWXHFI7LRr8mvp5t0sMjlGm_SDdpf0GJPHxO9Q7-aKj2L1gcStBzR9rCw9HhS0iqo52poHd07Pu22_FDR0_obaAdLF6AToBo6d8sxrYo1nWOCFm1dC-d5Qk5u5dc_JavFqHDPCWVcmjwMlHaSC2Wlki4QOsik06GCZ3vk4-w_p6ZhP8ciHOcprIJQMOkNwXjkw_yGi5r4499dd1Fw827I2F1dGF1-TxsDkGoltNPCBNJFAAKZtoYLDmhPR1kW6swj6zOxp40ZGaeLSe-Rt_NmMAB4qqMLN5pUfQRuC8fSI8_qWTIfCRcAsGHN6ZF4af4sDXW5pRj-qEjGMXEoVuzF_4f1htztDI4O08Nu7-Aluccw4AccO4vWyWp5OXGvALGV2etGLSj5dtua-AcwuVc8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwELbGJiFeEL8JDDASTDwsLLEdJ36Y0Lauahl0FWzT3oJjO1BpSsaaMvVf5K_iLknbdQLe9ho7iZPz3X22774j5I0RWWRi43xQHeYLEUW-ljbwtYmEDAS6NExw_jyQvWPx8TQ6XSG_Z7kwGFY5s4m1obalwT3yLcDdDLSLwwI-b8Mihp3uh_OfPlaQwpPWWTkN3ZZZsNs13Vib5HHgppewnBtv9zsg-7eMdfeP9np-W3HAN1HEK59rAXBe84Rlxrg413mSaATxCs8bLcs1vN-G1uWAHFhoXJLkTDGZGKFimzkOz71F1mLw-qBta7v7g-GX-Y4PMnAmMm74hThXwdYvGCoGt6PBYYIvuca6gsDfYO_16M0r7rB7j9xtcSzdaSbefbLiigdkY9gQYU836dEir2u8STfocEGRPX1I9A79aupULdocTtCqpN1RYenhpKJ1gM_lyDq6d3jS7_ihoifNN9AeljFAh0A1dO5XY1oXbjrDZC3auRLa84gc38ivf0xWi7JwTwllXJo8DJR2kgtlpZIuEDrIpNOhgmd75P3sP6emZULHghxnKayIUDDpNcF45N38hvOGBOTfXXdRcPNuyN5dXygvvqetMUi1EtppYQLpIgCETFvDBQfkp6MsC3XmkfWZ2NPWpIzThQJ45PW8GYwBnvDowpWTuo_ALeJYeuRJM0vmI-ECwDasPz0SL82fpaEutxSjHzXhOCYRxYo9-_-wXpHboJHpp_7g4Dm5wzD2B3w8i9bJanUxcS8AvFXZy1YrKPl204r4BxIfW3c
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Scoping+Review+to+Find+Out+Worldwide+COVID-19+Vaccine+Hesitancy+and+Its+Underlying+Determinants&rft.jtitle=Vaccines+%28Basel%29&rft.au=Biswas%2C+Md+Rafiul&rft.au=Mahmood+Saleh+Alzubaidi&rft.au=Shah%2C+Uzair&rft.au=Abd-Alrazaq%2C+Alaa+A&rft.date=2021-10-25&rft.pub=MDPI+AG&rft.eissn=2076-393X&rft.volume=9&rft.issue=11&rft.spage=1243&rft_id=info:doi/10.3390%2Fvaccines9111243&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2076-393X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2076-393X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2076-393X&client=summon